Biotech Stocks Continue Momentum in After-Hours Trading Despite Lack of Fresh News
ByAinvest
Wednesday, Dec 17, 2025 11:29 pm ET1min read
ACB--
ELDN--
EUDA--
LXEO--
SLDB--
Several small- and mid-cap biotech stocks, including Spyre Therapeutics, The Oncology Institute, and Solid Biosciences, posted notable gains in after-hours trading despite no new company updates. The movement was driven by investor sentiment and sector momentum, with the biotech sector showing renewed strength. Other stocks, such as Aurora Cannabis and EUDA Health Holdings, also recorded gains without new news. Lexeo Therapeutics and Eledon Pharmaceuticals posted modest gains.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet